A 3-cycle Plan-Do-Study-Act intervention resulted in increased nurse and physician education on mucositis and a nurse-driven protocol that reduced MBI-LCBIs by 25%.
Higher proportions of patients receiving olanzapine reported only mild or no nausea compared with patients receiving placebo.
This study addressed the dearth of information on the incidence of psychiatric disorders related to corticosteroid-containing treatment in patients with hematologic malignancies.
Gastrointestinal-tract involvement may be a comorbid condition in patients with Waldenström macroglobulinemia.
Busulfan usage, high ferritin levels prior to HSCT, and treatment with some antibody-drug conjugates were deemed to be risk facts for VOD/SOS.
Some studies have found a link between intestinal microbiota composition and development of acute graft-versus-host disease.
Nonwhite race, poor acute phase nausea control, and treatment with cisplatin were all associated with higher self-reported nausea severity scores.
Patients taking opioids for cancer-related pain at outpatient supportive pain consultations may be at higher risk for aberrant opioid and drug use behavior.
In clinical practice, most physicians and nurse practitioners do not feel comfortable enough with their medical knowledge of cannabis to offer it to patients.
An overview of the potential immune-related adverse events that can arise from treatment with checkpoint inhibitors.
More than 90 medical societies have called on the US government to reverse a policy allowing step therapy under Medicare Advantage.
Researchers investigated cancer-related fatigue in 16 patients with multiple myeloma who were treated with bortezomib, lenalidomide, or thalidomide.